FDAClass IIDecember 18, 2024

Levothyroxine Sodium Tablets recall: Subpotent

Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured…

Why was Levothyroxine Sodium Tablets recalled?

Subpotent and Superpotent Drug

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: 3115869, Exp. Date 03/2025

Product
Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only, Manufactured…
Recalling firm
Mylan Institutional, Inc.
Quantity
205 cartons
Distribution
Nationwide in the USA.
Recall date
December 18, 2024
Classification
Class II
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls